by Eric Christianson | Feb 11, 2026 | Cardiovascular Medication and Disease State Clinical Pearls
Fibrates are lipid-lowering agents that are primarily used to reduce triglycerides. They are most beneficial in patients with significantly elevated triglyceride levels, particularly those above 500 mg/dL, where the primary clinical goal is reducing the risk of...
by Eric Christianson | Feb 8, 2026 | Neurology, Pain, and Musculoskeletal Medication and Disease State Clinical Pearls
Oral bisphosphonates (i.e., alendronate) are commonly used to treat osteoporosis, and proper administration is one of the most important concepts for the NAPLEX exam. These medications must be taken first thing in the morning on an empty stomach with a full glass of...
by Eric Christianson | Feb 4, 2026 | Cardiovascular Medication and Disease State Clinical Pearls
Rhabdomyolysis happens when muscle cells break down and release their contents into the blood. These substances can damage the kidneys and cause serious problems like kidney failure. It is often triggered by medications, injuries, extreme exercise, or drug...
by Eric Christianson | Feb 1, 2026 | Endocrine Case Studies
In this case scenario, a patient is prescribed Carafate (sucralfate) for GI concerns, and it leads to a case of hypothyroidism due to the Carafate Synthroid drug interaction. Robert H. is a 62-year-old male with a history of primary hypothyroidism that has been well...
by Eric Christianson | Jan 28, 2026 | Psychiatry and Addiction Medicine Case Studies
This was a case I came across recently where duloxetine was added to a patient’s regimen. The provider did not adequately assess the medication and recognize that the patient was already taking an SNRI in Effexor. This led to a case of duplicate SNRI therapy....
